We are live on ! Find out more
MEDS

DataMeds AI
MEDS

5 hedge funds and large institutions have $1.53M invested in DataMeds AI in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.49% more ownership

Funds ownership: 0% → 0.49% (+0.49%)

Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$743K
2
HF
HRT Financial
New York
+$262K
3
Citadel Advisors
Citadel Advisors
Florida
+$101K
4
VFIC
Valley Forge Investment Consultants
Pennsylvania
+$77.6K
5
UBS Group
UBS Group
Switzerland
+$9.95K

Top Sellers

No sellers this quarter

MEDS Hedge Fund Activity: Q1 2025 in Review

5 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI (MEDS) for Q1 2025, worth a combined $1.53M.

Buyers outnumbered sellers: 5 funds opened new MEDS positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $743K.

  • 5 institutional investors held DataMeds AI (MEDS) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $1.53M of DataMeds AI stock for Q1 2025.
  • 5 funds opened new DataMeds AI positions in Q1 2025 and 0 closed out, a net change of +5 holders.
  • The largest DataMeds AI buyer in Q1 2025 was Millennium Management, an estimated $743K added.

Based on aggregated 13F filings for Q1 2025.